statistiche ricercatore

Continente	#
NA - Nord America	1.186
EU - Europa	885
AS - Asia	314
SA - Sud America	52
Continente sconosciuto - Info sul continente non disponibili	16
AF - Africa	7
OC - Oceania	2
Totale	2.462

Nazione	#
US - Stati Uniti d'America	1.159
PL - Polonia	390
RU - Federazione Russa	203
IT - Italia	128
SG - Singapore	78
CN - Cina	72
VN - Vietnam	48
IE - Irlanda	47
HK - Hong Kong	45
BR - Brasile	38
SE - Svezia	30
KR - Corea	22
FR - Francia	20
FI - Finlandia	17
DE - Germania	16
GB - Regno Unito	16
IN - India	16
CA - Canada	14
ID - Indonesia	11
CO - Colombia	6
MX - Messico	6
RO - Romania	6
AR - Argentina	5
JP - Giappone	5
JO - Giordania	4
HN - Honduras	3
IQ - Iraq	3
NL - Olanda	3
UA - Ucraina	3
ZA - Sudafrica	3
AE - Emirati Arabi Uniti	2
AU - Australia	2
CI - Costa d'Avorio	2
TH - Thailandia	2
BD - Bangladesh	1
BE - Belgio	1
CH - Svizzera	1
CR - Costa Rica	1
EC - Ecuador	1
EE - Estonia	1
EG - Egitto	1
ES - Italia	1
GY - Guiana	1
JM - Giamaica	1
LT - Lituania	1
NI - Nicaragua	1
NP - Nepal	1
PK - Pakistan	1
PY - Paraguay	1
SK - Slovacchia (Repubblica Slovacca)	1
TN - Tunisia	1
TR - Turchia	1
TW - Taiwan	1
UZ - Uzbekistan	1
VG - Isole Vergini Britanniche	1
Totale	2.446

Nome	#
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced anti-proliferative profiles.	279
Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines	276
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2 S release in vivo.	260
Phaseolus vulgaris L. Extract: Alpha-Amylase Inhibition against Metabolic Syndrome in Mice .	243
Design, Synthesis, and X-ray of Selenides as New Class of Agents for Prevention of Diabetic Cerebrovascular Pathology	242
Intra-articular mucilages: behavioural and histological evaluations for a new model of articular pain.	224
Mesenchymal stem cells, implications for pain therapy.	224
Toxicological profile of the pain-relieving antioxidant compound thioctic acid in its racemic and enantiomeric forms.	192
Comparative assessment of the activity of racemic and dextrorotatory forms of thioctic (alpha-lipoic) acid in low back pain: preclinical and clinical evidences, from an open randomized trial.	182
Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation.	175
Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity	165
Totale	2.462

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	67	0	0	0	7	1	8	0	7	6	6	6	26
2022/2023	197	18	55	13	3	6	29	33	9	19	1	11	0
2023/2024	70	2	9	11	7	1	8	4	18	1	4	4	1
2024/2025	581	27	52	40	81	168	105	4	18	14	22	25	25
2025/2026	629	51	61	24	56	63	25	83	30	64	57	21	94
2026/2027	155	57	20	48	30	0	0	0	0	0	0	0	0
Totale													2.462